Phreesia PHR 2026Q2 Earnings Preview Upside Ahead on Revenue Growth
Generated by AI AgentAinvestweb
Monday, Sep 1, 2025 7:33 pm ET1min read
PHR--
Forward-Looking Analysis
Analyst expectations for Phreesia’s 2026Q2 earnings highlight positive revenue growth, driven by continued adoption of its healthcare engagement platform. Projected revenue is estimated at $120–$125 million, with net income anticipated in the range of $1.5–$2.0 million. Earnings per share (EPS) are forecasted between $0.03 and $0.05. Analysts from major banks have upgraded Phreesia’s outlook in recent months, citing strong customer retention and expansion into new healthcare segments. No recent downgrades have been reported, and the average price target remains above $20 per share, reflecting confidence in the company’s long-term growth trajectory.
Historical Performance Review
Phreesia reported 2026Q1 results with revenue of $115.94 million, reflecting continued growth in its healthcare engagement solutions. However, the company posted a net loss of $3.91 million, or $0.07 per share, due to increased R&D and operational expenses. Gross profit stood at $77.87 million, indicating healthy margins, but profitability remains under pressure from strategic investments.
Additional News
Recent news related to PhreesiaPHR-- is minimal and unrelated to earnings. Phreesia has not announced any major product launches, M&A activity, or CEO statements. Meanwhile, activity surrounding Phreesia’s educational technology partners, such as the recent upgrades to teaching management systems at Hunan Institute of Technology, highlights broader trends in digital transformation across sectors, including healthcare.
Summary & Outlook
Phreesia’s 2026Q2 earnings report is expected to show improved revenue compared to its Q1 loss, supported by growing demand for its digital health solutions. With a projected EPS increase and favorable analyst sentiment, the company appears to be on a path toward profitability. While net income remains a concern due to ongoing investments, gross profit margins remain stable, suggesting underlying operational strength. Key catalysts include customer retention and product innovation. Overall, Phreesia’s financial health is improving, and the outlook is cautiously bullish.
Analyst expectations for Phreesia’s 2026Q2 earnings highlight positive revenue growth, driven by continued adoption of its healthcare engagement platform. Projected revenue is estimated at $120–$125 million, with net income anticipated in the range of $1.5–$2.0 million. Earnings per share (EPS) are forecasted between $0.03 and $0.05. Analysts from major banks have upgraded Phreesia’s outlook in recent months, citing strong customer retention and expansion into new healthcare segments. No recent downgrades have been reported, and the average price target remains above $20 per share, reflecting confidence in the company’s long-term growth trajectory.
Historical Performance Review
Phreesia reported 2026Q1 results with revenue of $115.94 million, reflecting continued growth in its healthcare engagement solutions. However, the company posted a net loss of $3.91 million, or $0.07 per share, due to increased R&D and operational expenses. Gross profit stood at $77.87 million, indicating healthy margins, but profitability remains under pressure from strategic investments.
Additional News
Recent news related to PhreesiaPHR-- is minimal and unrelated to earnings. Phreesia has not announced any major product launches, M&A activity, or CEO statements. Meanwhile, activity surrounding Phreesia’s educational technology partners, such as the recent upgrades to teaching management systems at Hunan Institute of Technology, highlights broader trends in digital transformation across sectors, including healthcare.
Summary & Outlook
Phreesia’s 2026Q2 earnings report is expected to show improved revenue compared to its Q1 loss, supported by growing demand for its digital health solutions. With a projected EPS increase and favorable analyst sentiment, the company appears to be on a path toward profitability. While net income remains a concern due to ongoing investments, gross profit margins remain stable, suggesting underlying operational strength. Key catalysts include customer retention and product innovation. Overall, Phreesia’s financial health is improving, and the outlook is cautiously bullish.
This internal account is for our software. It'll answer users' questions about subscription products, aiming to boost adoption and retention.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet